Block Grant UR6PS000340

This $1,272,341 cooperative agreement from the Centers for Disease Control and Prevention will support efforts to promote pre-exposure prophylaxis (PrEP) adherence among men who have sex with men of color. Awarded under the HIV Demonstration, Research, Public and Professional Education Projects program (CFDA 93.941), the University of North Carolina at Chapel Hill will work to develop and test improved HIV prevention strategies from September 2021 through October 2022. A subaward of $250,000...

The City and County of San Francisco's Public Health Department received a $643,882 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) National Center for HIV/AIDS under the HIV Prevention and Surveillance Activities-Health Department Based program (CFDA 93.940) to operate the Medical Monitoring Project (MMP) in San Francisco through September 29, 2030. The MMP serves as a key surveillance activity that collects and analyzes behavioral and clinical data from a...

Federal Cooperative Agreement Summary Emory University received a $744,940 Cooperative Agreement from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded June 16, 2026, with a completion date of May 31, 2028. The award funds development and testing of a scalable, platform-agnostic digital HIV prevention intervention titled "The Eleccion Cohort." The research will be conducted in Peru,...

Federal Cooperative Agreement Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2.3 million Cooperative Agreement to the Research Foundation of the City University of New York (RFCUNY) under the Allergy and Infectious Diseases Research program (CFDA 93.855) for Proyecto Vida, a three-year longitudinal epidemiological study examining HIV incidence and prevention engagement among men who have sex with men (MSM) in Colombia. Awarded June 4, 2026, with completion...

Federal Cooperative Agreement Summary The Philadelphia Department of Public Health Division of HIV Health received a $579,853 Cooperative Agreement from the Centers for Disease Control and Prevention's National Center for HIV/AIDS under the HIV Prevention and Surveillance Activities-Health Department Based program (CFDA 93.940), effective September 30, 2025, through September 29, 2030. This five-year award supports comprehensive HIV and tuberculosis prevention initiatives including targeted...

Federal Project Grant Award Summary The John E. Fogarty International Center awarded Partnership For Research And Action For Health a $192,292 Project Grant (CFDA 93.989: International Research and Research Training) effective April 1, 2026 through March 31, 2029 to reduce HIV-related stigma and enhance prevention among men who have sex with men (MSM) in Georgia. The award funds the adaptation and pilot testing of evidence-based digital health interventions—specifically video content and...

Federal Grant Award Summary The National Institute on Minority Health and Health Disparities (NIMHD) awarded The Research Foundation for the State University of New York (SUNY Downstate Health Sciences University) a $1.25M Project Grant on May 6, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct an efficacy trial of the "Our Family, Our Voices" (OFOV) intervention. This community-driven, HIV status-neutral intervention is designed to...

Federal Cooperative Agreement Summary: PS25-0008 Medical Monitoring Project The National Center for HIV/AIDS, a division of the Centers for Disease Control and Prevention, awarded a $1.796 million Cooperative Agreement to the New Jersey Department of Health (NJDOH) under the HIV Prevention and Surveillance Activities-Health Department Based program (CFDA 93.940). Effective September 30, 2025, through September 29, 2030, this five-year award supports NJDOH's implementation of the Medical...

Federal Cooperative Agreement Summary The National Center for HIV/AIDS, under the Centers for Disease Control and Prevention (CDC), awarded a $6.09 million cooperative agreement (CFDA 93.084: Prevention of Disease, Disability, and Death by Infectious Diseases) to the University of Colorado-Denver on September 30, 2025, for a three-year project period through September 29, 2028. The award, designated PS24-039, funds research to understand integrative care and support pathways to healthy aging for...

Federal Cooperative Agreement Summary Health Research, Inc. (AIDS Institute) received a $592,926 Cooperative Agreement award effective September 30, 2025, through September 29, 2030, from the Centers for Disease Control and Prevention's National Center for HIV/AIDS under the Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance program (CFDA 93.944). The organization will conduct the Medical Monitoring Project (MMP), a surveillance initiative designed to...